Sunshine Biopharma Inc. Annual Operating Margin in % from 2019 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Sunshine Biopharma Inc. annual/quarterly Operating Margin history and growth rate from 2019 to 2024.
  • Sunshine Biopharma Inc. Operating Margin for the quarter ending September 30, 2024 was -14.8 %, a 88.8% increase year-over-year.
  • Sunshine Biopharma Inc. annual Operating Margin for 2024 was -16.7 %, a 16.1% increase from 2023.
  • Sunshine Biopharma Inc. annual Operating Margin for 2023 was -19.9 %, a 96.8% increase from 2022.
  • Sunshine Biopharma Inc. annual Operating Margin for 2022 was -621 %, a 41.8% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -16.7 +3.2 +16.1% Jan 1, 2024 Dec 31, 2024
2023 -19.9 +601 +96.8% Jan 1, 2023 Dec 31, 2023
2022 -621 +447 +41.8% Jan 1, 2022 Dec 31, 2022
2021 -1.07K -260 -32.2% Jan 1, 2021 Dec 31, 2021
2020 -808 +2.23K +73.4% Jan 1, 2020 Dec 31, 2020
2019 -3.04K Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.